Naveris, Inc., a leader in molecular diagnostics for viral cancers, announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.
The...
Latham BioPharm Group, part of Sia Partners, is excited to announce the addition of a new capability centered around Digital Health Consulting. Digital transformation is...
Alpenglow Biosciences announced a collaboration with Mayo Clinic to integrate Alpenglow's 3D spatial biology platform to accelerate drug development and advance clinical diagnostics. Alpenglow has...
PSG, part of Dover and a global pump, metering and dispensing-solution expert, is proud to announce the creation and launch of its new PSG Biotech brand. This...
